Skip to main content
. 2022 Mar 6;23(5):2871. doi: 10.3390/ijms23052871
1α,25(OH)2D3 1α,25-dihydroxy-vitamin D3
ABT abatacept
ACPA anticitrullinated protein antibody
ADA adalimumab
AtoM arthritis-associated osteoclastogenic macrophages
BAR baricitinib
bDMARDs biological disease-modifying antirheumatic drugs
CIA collagen-induced arthritis
csDMARDs conventional synthetic disease-modifying antirheumatic drugs
CTLA-4 cytotoxic T-lymphocyte-associated protein-4
CZP certolizumab pegol
DC-OC dendritic cell-derived osteoclast
DKK1 dickkopf1
ETN etanercept
FIL filgotinib
FLS fibroblast-like synoviocyte
Fox forkhead box protein
IFX infliximab
M-CSF macrophage colony-stimulating factor
Mo-OC monocyte-derived osteoclast
mTORC1 mammalian target of rapamycin complex 1
MTX methotrexate
NFATc1 nuclear factor of activated T cell c1
OPG osteoprotegerin
PEF peficitinib
RA rheumatoid arthritis
RANK receptor activator of nuclear factor-κB
RANKL receptor activator of nuclear factor-κB ligand
Runx runt-related transcription factor
S1P sphingosine-1-phosphate
SAR sarilumab
sFRP secreted Frizzled-related protein
TCZ tocilizumab
TGF-b transforming growth factor-beta
TNF-a tumor necrosis factor-alpha
TOF tofacitinib
tsDMARDs targeted synthetic disease-modifying antirheumatic drugs
UPA upadacitinib
Wnt wingless-related MMTV integration site